Full Text View
Tabular View
No Study Results Posted
Related Studies
A Trial of ZD6474 (Zactima), Paclitaxel, Carboplatin, 5-Fluorouracil, and XRT Followed by Surgery
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by Fox Chase Cancer Center.
Recruitment status was  Recruiting
Study NCT01183559   Information provided by Fox Chase Cancer Center

First Received on August 13, 2010.   Last Updated on February 8, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Esophageal Neoplasms
More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Esophageal Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Head and Neck Neoplasms
Neoplasms
Neoplasms by Site
Interventions listed in this trial
ZD6474 (Zactima)
Additional drug interventions recognized in this trial
Carboplatin
Fluorouracil
Paclitaxel
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Immunologic Factors
Immunosuppressive Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Fox Chase Cancer Center
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services